Xeris Biopharma Holdings, Inc. (XERS)
USD 4.16
(-0.48%)
USD 4.16
(-0.48%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 229.19 Million USD | 15.72% |
| 2023 | 198.05 Million USD | 0.0% |
| 2022 | 198.05 Million USD | 124.89% |
| 2021 | 88.06 Million USD | 1.2% |
| 2020 | 87.02 Million USD | 172.88% |
| 2019 | 31.89 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 229.19 Million USD | 15.72% |
| 2024 Q4 | 269.8 Million USD | 0.41% |
| 2024 Q2 | 229.19 Million USD | 0.55% |
| 2024 Q1 | 227.94 Million USD | 1.31% |
| 2024 Q3 | 268.69 Million USD | 17.24% |
| 2023 Q1 | 138.5 Million USD | 0.32% |
| 2023 FY | 198.05 Million USD | 0.0% |
| 2023 Q4 | 224.98 Million USD | 13.39% |
| 2023 Q3 | 198.41 Million USD | -11.81% |
| 2023 Q2 | 224.98 Million USD | 62.44% |
| 2022 Q1 | 87.71 Million USD | 0.27% |
| 2022 FY | 198.05 Million USD | 124.89% |
| 2022 Q4 | 138.06 Million USD | 0.06% |
| 2022 Q3 | 137.98 Million USD | 56.68% |
| 2022 Q2 | 88.06 Million USD | 0.4% |
| 2021 Q1 | 119.39 Million USD | 9.06% |
| 2021 Q4 | 87.47 Million USD | 0.24% |
| 2021 Q3 | 87.27 Million USD | 0.29% |
| 2021 Q2 | 87.02 Million USD | -27.11% |
| 2021 FY | 88.06 Million USD | 1.2% |
| 2020 Q3 | 58.48 Million USD | 0.31% |
| 2020 Q4 | 109.47 Million USD | 87.19% |
| 2020 Q2 | 58.3 Million USD | 0.31% |
| 2020 Q1 | 58.12 Million USD | 79.38% |
| 2020 FY | 87.02 Million USD | 172.88% |
| 2019 FY | 31.89 Million USD | 0.0% |
| 2019 Q3 | 32.14 Million USD | 0.79% |
| 2019 Q2 | 31.89 Million USD | 0.78% |
| 2019 Q1 | 31.64 Million USD | 74.17% |
| 2019 Q4 | 32.4 Million USD | 0.82% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | 18.16 Million USD | 0.64% |
| 2018 Q3 | 18.05 Million USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | 34.563% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1486.756% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -733.877% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -95.567% |
| MiMedx Group, Inc. | 48.09 Million USD | -376.498% |
| Novavax, Inc. | 280.63 Million USD | 18.331% |
| Seer, Inc. | 28.25 Million USD | -711.037% |
| Acelyrin, Inc. | 1.19 Million USD | -19095.226% |
| IO Biotech, Inc. | 2.49 Million USD | -9089.695% |
| Ardelyx, Inc. | 55.98 Million USD | -309.401% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -222.913% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -997.436% |
| Fortress Biotech, Inc. | 88.59 Million USD | -158.704% |
| Fortress Biotech, Inc. | 88.59 Million USD | -158.704% |
| Geron Corporation | 85.89 Million USD | -166.815% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -99.001% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -3394.298% |
| Incyte Corporation | 38.28 Million USD | -498.613% |
| Innoviva, Inc. | 449.07 Million USD | 48.964% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -6893.927% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3617.616% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 6.6 Million USD | -3369.962% |
| Onconetix, Inc. | 9.88 Million USD | -2218.393% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -71972.642% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -28251.117% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -7880.188% |
| Vaxcyte, Inc. | 29.22 Million USD | -684.256% |
| Precigen, Inc. | 7.09 Million USD | -3129.407% |
| Pharming Group N.V. | 171.54 Million USD | -33.604% |
| ContextLogic Inc. | 6 Million USD | -3719.85% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -23576.756% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -974.45% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -278.334% |
| AlloVir, Inc. | 27.42 Million USD | -735.579% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -107.68% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -79028.79% |
| Summit Therapeutics Inc. | 106.09 Million USD | -116.016% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -13917.798% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3591.865% |
| Senti Biosciences, Inc. | 37.66 Million USD | -508.482% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -126.062% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -235.909% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2893.067% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -544.605% |
| Chimerix, Inc. | 2.14 Million USD | -10589.879% |
| PDS Biotechnology Corporation | 23.85 Million USD | -860.903% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1261.8% |
| CRISPR Therapeutics AG | 238.63 Million USD | 3.956% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -613.591% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -64.85% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -703.024% |
| Precision BioSciences, Inc. | 31.26 Million USD | -632.989% |
| Dyadic International, Inc. | 136.92 Thousand USD | -167279.445% |
| Elevation Oncology, Inc. | 30.13 Million USD | -660.497% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -4101.485% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -119.991% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 91.456% |
| Aptorum Group Limited | 3.36 Million USD | -6716.298% |
| Bicycle Therapeutics plc | 44.95 Million USD | -409.812% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -226821.782% |
| Clearside Biomedical, Inc. | 43 Million USD | -432.99% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -36747.25% |
| GT Biopharma, Inc. | 58 Thousand USD | -395056.897% |
| Alkermes plc | 290.73 Million USD | 21.167% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -403.606% |
| Jaguar Health, Inc. | 35.86 Million USD | -539.127% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -10710.896% |
| AbCellera Biologics Inc. | 77.38 Million USD | -196.189% |
| PureTech Health plc | 25.51 Million USD | -798.365% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -50766.789% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -501.488% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -25197.02% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1666.269% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -3162.97% |
| AnaptysBio, Inc. | 17.81 Million USD | -1186.578% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1078.663% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -285218.942% |
| Molecular Templates, Inc. | 12.23 Million USD | -1774.007% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -70.397% |
| Vaxxinity, Inc. | 15.16 Million USD | -1411.017% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -796.819% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -13765.154% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -833.873% |
| Structure Therapeutics Inc. | 5.45 Million USD | -4103.025% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -48150.737% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -3253.197% |
| ImmuCell Corporation | 11.96 Million USD | -1814.823% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -97648.122% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -106998.598% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | -14.236% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2226.34% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -269.216% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -121.364% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -9.065% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -6343.379% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -13485.714% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -76115.607% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -815.226% |
| Aptose Biosciences Inc. | 1 Million USD | -22596.538% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2647670.333% |
| Soligenix, Inc. | 3.49 Million USD | -6458.506% |
| Century Therapeutics, Inc. | 48.17 Million USD | -375.786% |
| Kura Oncology, Inc. | 17.2 Million USD | -1232.506% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -147.954% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -144957.595% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -10560.047% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1540.125% |
| Autolus Therapeutics plc | 52.96 Million USD | -332.705% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -4090.73% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -447.74% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 0.105% |
| GRI Bio, Inc. | 14 Thousand USD | -1636978.571% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1744.744% |
| IGM Biosciences, Inc. | 40.5 Million USD | -465.82% |
| INmune Bio, Inc. | 10.43 Million USD | -2095.947% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -27.592% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3779.951% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -280496.229% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -27618.772% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -342.667% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -293.252% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -296.031% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 52.335% |
| Verastem, Inc. | 41.55 Million USD | -451.51% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -4144.278% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1915.397% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2235.585% |
| Histogen Inc. | 4.62 Million USD | -4858.698% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -6682.806% |
| Organovo Holdings, Inc. | 1.39 Million USD | -16341.248% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -398.223% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -4312.611% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -979.104% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1073394.145% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -170.95% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -109550.273% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -658.509% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -141099.628% |
| Apollomics, Inc. | 4.66 Million USD | -4817.207% |
| Amarin Corporation plc | 8.73 Million USD | -2523.223% |
| Mesoblast Limited | 118.92 Million USD | -92.722% |
| Turnstone Biologics Corp. | 3.21 Million USD | -7031.021% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -170.675% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -92689.879% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -134.81% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -20.662% |
| Better Therapeutics, Inc. | 14.88 Million USD | -1440.262% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -648.648% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -106.612% |
| NLS Pharmaceutics AG | 1.63 Million USD | -13928.558% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -3638.842% |
| Gritstone bio, Inc. | 104.77 Million USD | -118.746% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -8126.525% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -468880.97% |
| Avid Bioservices, Inc. | 207.83 Million USD | -10.276% |
| Insmed Incorporated | 1.2 Billion USD | 80.964% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -3315.154% |
| OmniAb, Inc. | 25.56 Million USD | -796.643% |
| Alector, Inc. | 38.91 Million USD | -488.907% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -7.131% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -1412.712% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 52.096% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1071.913% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -262.833% |
| Immunic, Inc. | 1.33 Million USD | -17080.735% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -622.271% |
| Veracyte, Inc. | 12.63 Million USD | -1714.656% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 64.459% |
| FibroGen, Inc. | 170.45 Million USD | -34.458% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2423.852% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -112297.566% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.046% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -619335.135% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -5309.275% |
| TG Therapeutics, Inc. | 110.79 Million USD | -106.86% |
| Galecto, Inc. | 249 Thousand USD | -91944.578% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -13656.963% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 86.341% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -3032.308% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -4146.637% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -8126.525% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -752.613% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -408.488% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -16051.586% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -406.656% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -430.916% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -375.214% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 72.995% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -22207.908% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1992.113% |
| NexImmune, Inc. | 68.8 Thousand USD | -332982.882% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1614603.396% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 91.521% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -58366.794% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -3218.723% |
| Ainos, Inc. | 5.96 Million USD | -3743.194% |
| Pluri Inc. | 29.61 Million USD | -673.98% |
| Prothena Corporation plc | 11.83 Million USD | -1836.553% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -808.227% |
| Celularity Inc. | 65.41 Million USD | -250.354% |
| Rallybio Corporation | 392 Thousand USD | -58367.092% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1459.653% |
| MeiraGTx Holdings plc | 89.26 Million USD | -156.756% |
| Omeros Corporation | 338.28 Million USD | 32.248% |
| Humacyte, Inc. | 58.1 Million USD | -294.436% |
| Immunocore Holdings plc | 84.03 Million USD | -172.743% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -12268.645% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4599.426% |
| Blueprint Medicines Corporation | 774.12 Million USD | 70.393% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -4467.377% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -270.751% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -120.173% |
| Pulmatrix, Inc. | 8.75 Million USD | -2517.531% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -3213.445% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1554.809% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -98.699% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -626.483% |
| Cytokinetics, Incorporated | 755.77 Million USD | 69.675% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -1612.425% |
| Nutriband Inc. | 241.28 Thousand USD | -94887.67% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -4092.263% |
| Vor Biopharma Inc. | 35.66 Million USD | -542.712% |
| Roivant Sciences Ltd. | 499.74 Million USD | 54.139% |
| Evogene Ltd. | 1.13 Million USD | -20039.807% |
| ProKidney Corp. | 4.41 Million USD | -5093.542% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -18594.209% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -415364.516% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 86.827% |
| CorMedix Inc. | 667.63 Thousand USD | -34228.942% |
| BioLineRx Ltd. | 11.59 Million USD | -1877.319% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -488.877% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -219.176% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1291.06% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -9250.933% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -33854.222% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -400.712% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -352501.538% |
| MediciNova, Inc. | 215.92 Thousand USD | -106043.308% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -9086.012% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -18074.933% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -22.975% |
| Biomea Fusion, Inc. | 10.29 Million USD | -2126.02% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 44.777% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3750.655% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -6284.15% |
| Absci Corporation | 15.95 Million USD | -1336.304% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2401.812% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1462.204% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -736.006% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1769.726% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1732.648% |
| Allakos Inc. | 41.46 Million USD | -452.734% |
| Imunon, Inc. | 1.62 Million USD | -14006.544% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -2018.021% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -151682.119% |
| BioAtla, Inc. | 2.46 Million USD | -9216.707% |
| NLS Pharmaceutics AG | 1.63 Million USD | -13928.558% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -202723.894% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -140.947% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -4032.546% |
| XOMA Corporation | 124.45 Million USD | -84.163% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1110.537% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -430.94% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1418.324% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1957.739% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -780.048% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -988.897% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -65570.774% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -70097.83% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13945.933% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 84.713% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -139678.736% |
| UroGen Pharma Ltd. | 100.21 Million USD | -128.702% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -25.413% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -66074.764% |
| Orgenesis Inc. | 22.62 Million USD | -913.178% |
| Entera Bio Ltd. | 390 Thousand USD | -58666.923% |
| GH Research PLC | 343 Thousand USD | -66719.534% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -75044.59% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -23455.087% |
| Xencor, Inc. | 83.43 Million USD | -174.697% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -132631.232% |
| Replimune Group, Inc. | 75.86 Million USD | -202.088% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -18621.298% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2337.165% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -139678.736% |
| Portage Biotech Inc. | 47 Thousand USD | -487540.426% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -18074.933% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -9382.458% |
| OncoCyte Corporation | 2.86 Million USD | -7888.533% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -17540.716% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -152131.757% |
| Purple Biotech Ltd. | 351 Thousand USD | -65196.581% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -7155.176% |
| scPharmaceuticals Inc. | 40.26 Million USD | -469.15% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -347.7% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -161302.113% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -4281.399% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -757.173% |
| Curis, Inc. | 2.79 Million USD | -8102.971% |
| Daré Bioscience, Inc. | 5.31 Million USD | -4209.604% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -10627.661% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -40464.779% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1269.858% |
| BeiGene, Ltd. | 930.18 Million USD | 75.361% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -1374.608% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -160.61% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -19986.854% |
| Erasca, Inc. | 55.85 Million USD | -310.303% |
| bluebird bio, Inc. | 330.32 Million USD | 30.617% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 79.787% |
| DBV Technologies S.A. | 14.38 Million USD | -1493.707% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -9060.312% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4835.207% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 43.379% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -397.819% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4872.684% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -8916.168% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1115.674% |
| MacroGenics, Inc. | 33.97 Million USD | -574.667% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -995.35% |
| Prime Medicine, Inc. | 13.63 Million USD | -1581.149% |
| Aditxt, Inc. | 18.21 Million USD | -1158.048% |
| Adagene Inc. | 22.3 Million USD | -927.446% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1397.687% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 62.487% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1029.409% |
| SciSparc Ltd. | 76 Thousand USD | -301467.105% |
| Vericel Corporation | 88.14 Million USD | -160.022% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -179.444% |
| Generation Bio Co. | 97.89 Million USD | -134.122% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -69562.918% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -805.965% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -11.303% |
| Invivyd, Inc. | 2.16 Million USD | -10486.189% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -328.667% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -6504115.703% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -4034.783% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -363695.238% |
| 2seventy bio, Inc. | 256.67 Million USD | 10.707% |
| ADMA Biologics, Inc. | 141.41 Million USD | -62.066% |
| Clene Inc. | 32.16 Million USD | -612.636% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3983.833% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -10341.503% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -352.303% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -47524.599% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -18.634% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -660.775% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1232.738% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -84.03% |
| Evaxion Biotech A/S | 10.86 Million USD | -2008.535% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -174.846% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -205.967% |
| Trevena, Inc. | 35.23 Million USD | -550.501% |
| Surrozen, Inc. | 3.37 Million USD | -6682.806% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -3428.187% |
| Cingulate Inc. | 3.13 Million USD | -7210.487% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -558902.439% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -749.17% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -45655.565% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -37908.458% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -300.649% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -49188.387% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -710.664% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1033.543% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -14638.971% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -18089.762% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1309.44% |
| ImmunityBio, Inc. | 883.67 Million USD | 74.064% |
| Korro Bio, Inc. | 33.2 Million USD | -590.189% |
| Kineta, Inc. | 1.31 Million USD | -17302.506% |
| BioVie Inc. | 6.11 Million USD | -3650.192% |
| Codexis, Inc. | 22.36 Million USD | -924.821% |
| Celularity Inc. | 65.41 Million USD | -250.354% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -343.07% |
| Celcuity Inc. | 37.44 Million USD | -512.053% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -102080.562% |
| Cibus, Inc. | 24.62 Million USD | -830.876% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -59740.992% |
| IN8bio, Inc. | 4.89 Million USD | -4584.059% |
| Kodiak Sciences Inc. | 181.63 Million USD | -26.184% |
| Annexon, Inc. | 31.35 Million USD | -630.955% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -205.441% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -9686.123% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -5772.175% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 84.232% |
| Eyenovia, Inc. | 16.1 Million USD | -1322.861% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -105.571% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -23168.122% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1900.445% |
| Arcellx, Inc. | 97.62 Million USD | -134.767% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -10565.007% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -764.448% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -7288.491% |
| Moolec Science SA | 2.64 Million USD | -8564.119% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -704.546% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3530.461% |
| Royalty Pharma plc | 6.13 Billion USD | 96.264% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -9441.674% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -198757.306% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -577.479% |
| Humacyte, Inc. | 58.1 Million USD | -294.436% |
| 89bio, Inc. | 27.1 Million USD | -745.474% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1625.056% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -8998.491% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -17029.372% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -116.087% |
| Notable Labs, Ltd. | 2.04 Million USD | -11085.505% |
| Liquidia Corporation | 3.5 Million USD | -6442.706% |
| Mustang Bio, Inc. | 2.49 Million USD | -9074.98% |
| Immunovant, Inc. | 138 Thousand USD | -165980.435% |
| Quantum-Si incorporated | 15.3 Million USD | -1397.687% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2528.036% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -57197.75% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -326.735% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -280496.229% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -2002.091% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -108785.025% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -112801.97% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1009.293% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -56771.216% |
| PepGen Inc. | 20.1 Million USD | -1040.027% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -39828.746% |
| United Therapeutics Corporation | 700 Million USD | 67.258% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -772.61% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -5035.405% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -25768.059% |
| XOMA Corporation | 124.45 Million USD | -84.163% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -83546.35% |
| Bionomics Limited | 239.61 Million USD | 4.352% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -11168.0% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1626.356% |
| uniQure N.V. | 138.4 Million USD | -65.59% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -168.301% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -22108.43% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -23168.122% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2423.852% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -13019.118% |
| Altimmune, Inc. | 671 Thousand USD | -34056.632% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 48.503% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1626.356% |
| Compugen Ltd. | 1.35 Million USD | -16864.545% |
| Peak Bio, Inc. | 10.72 Million USD | -2037.615% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -435.919% |
| Benitec Biopharma Inc. | 284 Thousand USD | -80601.056% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -171.056% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1050.499% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -1845.759% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -150.597% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1050.499% |
| Instil Bio, Inc. | 86.05 Million USD | -166.334% |
| argenx SE | 20 Million USD | -1045.955% |
| Immunome, Inc. | 1.65 Million USD | -13790.364% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -13125.101% |
| Verona Pharma plc | 51.32 Million USD | -346.514% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2243.946% |
| Shattuck Labs, Inc. | 4.2 Million USD | -5354.331% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -63212.431% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -5381.727% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -39077.949% |
| Moolec Science SA | 2.64 Million USD | -8564.119% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -658.678% |
| Design Therapeutics, Inc. | 3.05 Million USD | -7414.459% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -87377.481% |
| NeurAxis, Inc. | 224.26 Thousand USD | -102098.787% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1510.845% |
| Lumos Pharma, Inc. | 6.58 Million USD | -3380.501% |
| Achilles Therapeutics plc | 4.61 Million USD | -4866.219% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2243.946% |
| 180 Life Sciences Corp. | 1.32 Million USD | -17262.047% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1241.858% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -14638.971% |
| Nutriband Inc. | 241.28 Thousand USD | -94887.67% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -2144.11% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -27647.094% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 38.673% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -661.457% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -6097.926% |
| Palisade Bio, Inc. | 369 Thousand USD | -62011.382% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -55126.747% |
| Beam Therapeutics Inc. | 173.17 Million USD | -32.348% |
| Neurogene Inc. | 16.25 Million USD | -1309.972% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 25.622% |
| AEON Biopharma, Inc. | 278 Thousand USD | -82342.806% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -68315.224% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -214315.62% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -202.116% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -275.065% |
| Athira Pharma, Inc. | 1.58 Million USD | -14360.0% |
| Vaccinex, Inc. | 247 Thousand USD | -92689.879% |
| HCW Biologics Inc. | 6.45 Million USD | -3452.37% |
| XOMA Corporation | 124.45 Million USD | -84.163% |
| Nektar Therapeutics | 230.4 Million USD | 0.525% |
| Arvinas, Inc. | 3.4 Million USD | -6640.912% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13945.933% |
| Merus N.V. | 12.16 Million USD | -1784.484% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -78.459% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1559.121% |
| Rezolute, Inc. | 2.22 Million USD | -10186.849% |
| Clene Inc. | 32.16 Million USD | -612.636% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -130826.634% |
| BeyondSpring Inc. | 3.99 Million USD | -5636.946% |
| Synlogic, Inc. | 17.27 Million USD | -1226.721% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -17530.077% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -654731.429% |
| Peak Bio, Inc. | 10.72 Million USD | -2037.615% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -341.406% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2731.616% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -29.475% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -3147.711% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -167689.947% |
| MannKind Corporation | 382.37 Million USD | 40.062% |
| Ikena Oncology, Inc. | 10.73 Million USD | -2034.392% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -55936.919% |
| Gossamer Bio, Inc. | 212.46 Million USD | -7.873% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -131618.966% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2401.812% |
| Legend Biotech Corporation | 328.67 Million USD | 30.268% |
| Mural Oncology plc | 15 Million USD | -1427.024% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -383.26% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -10808.663% |
| Champions Oncology, Inc. | 7.43 Million USD | -2984.67% |
| REGENXBIO Inc. | 89.29 Million USD | -156.682% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -26715.468% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -41346.376% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -4133.303% |
| Vaxart, Inc. | 26.51 Million USD | -764.415% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1363.791% |
| Cellectis S.A. | 92.85 Million USD | -146.832% |
| Longeveron Inc. | 2.04 Million USD | -11129.348% |
| Repare Therapeutics Inc. | 3.41 Million USD | -6621.144% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 83.592% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -391.911% |
| Revolution Medicines, Inc. | 87.94 Million USD | -160.61% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -132380.347% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -5697.9% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -72200.0% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -130866.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 71.649% |
| Denali Therapeutics Inc. | 52.24 Million USD | -338.719% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1491.001% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -16580.568% |
| Cingulate Inc. | 3.13 Million USD | -7210.487% |
| Passage Bio, Inc. | 26.29 Million USD | -771.648% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -3338.725% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -56074.265% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -25536.577% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1014.688% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -18089.762% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -9250.456% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -7238.809% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -28160.296% |
| OmniAb, Inc. | 25.56 Million USD | -796.643% |
| Anew Medical, Inc. | 1.6 Million USD | -14179.813% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -674.742% |
| Lipocine Inc. | 17.16 Thousand USD | -1335045.054% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1869.333% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -561.866% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3779.951% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -300.873% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -112801.97% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -4337.386% |
| Ocugen, Inc. | 6.94 Million USD | -3201.988% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1522.132% |
| Q32 Bio Inc. | 1.31 Million USD | -17289.302% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -34005.804% |
| Alumis Inc. Common Stock | 32.58 Million USD | -603.471% |
| Equillium, Inc. | 824 Thousand USD | -27714.442% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2424.408% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -76092.297% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -50.488% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -348.181% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -29471.201% |
| Dominari Holdings Inc. | 3.02 Million USD | -7469.055% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -242463.527% |
| vTv Therapeutics Inc. | 529 Thousand USD | -43225.331% |
| Bio-Techne Corporation | 419.53 Million USD | 45.371% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -218.339% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -18.405% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1257.123% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -906.902% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3683.278% |
| Nkarta, Inc. | 88.33 Million USD | -159.445% |
| BioCardia, Inc. | 1.31 Million USD | -17328.973% |
| Iterum Therapeutics plc | 19.5 Million USD | -1074.796% |